Michael W. Wallace
Known title: COO/CFOCIK: 0001070123
Michael W. Wallace's purchase track record
How the stock did after each of Michael W. Wallace's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since May 3, 2022
Stock higher 6 months later
100%
3 months: 75%
Median 6-month return
+39.6%
3 months: +23.8%
Beat the S&P 500
100%
median +37.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/8/2023 | SPOK | $26K | +28.3% | +46.5% | +11.9% |
| 12/6/2022 | SPOK | $16K | +38.0% | +73.9% | +8.7% |
| 8/19/2022 | SPOK | $12K | +19.4% | +31.2% | -3.5% |
| 5/3/2022 | SPOK | $17K | -1.9% | +32.7% | -7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SPOK | ▼ Sell | Tax Withholding | 17,897 | $217K | 3/4/2026 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 30,525 | $371K | 3/4/2026 | View on chart |
| SPOK | ▲ Buy | Grant | 9,157 | $111K | 3/4/2026 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 22,865 | $302K | 1/5/2026 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 10,985 | $145K | 1/5/2026 | View on chart |
| SPOK | ▼ Sell | Open Market | 10,806 | $193K | 8/25/2025 | View on chart |
| SPOK | ▼ Sell | Open Market | 10,000 | $185K | 8/4/2025 | View on chart |
| SPOK | ▼ Sell | Open Market | 6,000 | $99K | 5/7/2025 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 34,682 | $584K | 3/7/2025 | View on chart |
| SPOK | ▲ Buy | Grant | 10,404 | $175K | 3/7/2025 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 20,334 | $343K | 3/7/2025 | View on chart |
| SPOK | ▼ Sell | Open Market | 10,000 | $165K | 3/4/2025 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 28,195 | $453K | 1/3/2025 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 13,237 | $212K | 1/3/2025 | View on chart |
| SPOK | ▼ Sell | Open Market | 12,000 | $191K | 11/19/2024 | View on chart |
| SPOK | ▼ Sell | Open Market | 25,000 | $370K | 8/20/2024 | View on chart |
| SPOK | ▼ Sell | Open Market | 40,000 | $689K | 3/1/2024 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 11,865 | $201K | 2/29/2024 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 26,307 | $445K | 2/29/2024 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 30,721 | $476K | 1/2/2024 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 14,415 | $223K | 1/2/2024 | View on chart |
| SPOK | ▼ Sell | Open Market | 20,000 | $333K | 12/1/2023 | View on chart |
| SPOK | ▲ Buy | Open Market | 2,500 | $26K | 3/8/2023 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 20,556 | $191K | 3/2/2023 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 9,271 | $86K | 3/2/2023 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 28,722 | $235K | 1/3/2023 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 13,948 | $114K | 1/3/2023 | View on chart |
| SPOK | ▲ Buy | Open Market | 2,000 | $16K | 12/6/2022 | View on chart |
| SPOK | ▲ Buy | Open Market | 1,690 | $12K | 8/19/2022 | View on chart |
| SPOK | ▲ Buy | Open Market | 2,313 | $17K | 5/3/2022 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 10,395 | $90K | 2/25/2022 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 4,689 | $41K | 2/25/2022 | View on chart |
| SPOK | ▼ Sell | Tax Withholding | 10,230 | $95K | 12/31/2021 | View on chart |
| SPOK | ▲ Buy | Option Exercise | 20,931 | $195K | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Spok Holdings supports hospitals on U.S. News Best Children's Hospitals list
Spok Holdings announced that its technology supports all leading hospitals named to the U.S. News & World Report 2026-2027 Best Children's Hospitals Honor Roll. This highlights the company's role in the healthcare sector by serving top-tier medical institutions. The news serves as a brand endorsement for Spok's digital health solutions within the pediatric care market.
Spok Holdings supports hospitals on U.S. News Best Children's Hospitals list. Spok Holdings announced that its technology supports all leading hospitals named to the U.S. News & World Report 2026-2027 Best Children's Hospitals Honor Roll. This highlights the company's role in the healthcare sector by serving top-tier medical institutions. The news serves as a brand endorsement for Spok's digital health solutions within the pediatric care market.